301263 泰恩康
已收盘 07-15 15:00:00
资讯
新帖
简况
医药生物:创新药及CXO继续爆发 关注玫瑰痤疮新药(泰恩康/科笛)
华福证券 · 07-12
医药生物:创新药及CXO继续爆发 关注玫瑰痤疮新药(泰恩康/科笛)
泰恩康最新公告:全资子公司收到药品注册受理通知书
证券之星 · 07-08
泰恩康最新公告:全资子公司收到药品注册受理通知书
泰恩康上涨5.2%,报40.7元/股
金融界 · 07-08
泰恩康上涨5.2%,报40.7元/股
泰恩康:布局老年慢性病领域药物研发
证券之星 · 06-30
泰恩康:布局老年慢性病领域药物研发
泰恩康:CKBA软膏白癜风适应症II期临床试验预计7月底公布结果
证券之星 · 06-24
泰恩康:CKBA软膏白癜风适应症II期临床试验预计7月底公布结果
6月20日泰恩康发布公告,股东减持569.43万股
证券之星 · 06-20
6月20日泰恩康发布公告,股东减持569.43万股
泰恩康(301263.SZ):硫酸氨基葡萄糖胶囊注册上市许可申请获受理
智通财经 · 06-20
泰恩康(301263.SZ):硫酸氨基葡萄糖胶囊注册上市许可申请获受理
中证全指食品与主要用品零售指数报9325.86点,前十大权重包含泰恩康等
金融界 · 06-20
中证全指食品与主要用品零售指数报9325.86点,前十大权重包含泰恩康等
泰恩康:公司“发教授”米诺地尔搽剂本月正式上市销售
证券之星 · 06-18
泰恩康:公司“发教授”米诺地尔搽剂本月正式上市销售
泰恩康:截止2025年6月10日,公司股东总户数为16,342户
证券之星 · 06-11
泰恩康:截止2025年6月10日,公司股东总户数为16,342户
医药商业板块异动拉升,泰恩康领涨12.67%
金融界 · 06-09
医药商业板块异动拉升,泰恩康领涨12.67%
每周股票复盘:泰恩康(301263)股东户数减少86户,户均持股增至4.26万股
证券之星 · 06-06
每周股票复盘:泰恩康(301263)股东户数减少86户,户均持股增至4.26万股
泰恩康:截止2025年5月30日,公司股东总户数为9,998户
证券之星 · 06-04
泰恩康:截止2025年5月30日,公司股东总户数为9,998户
【投融资动态】安徽泰恩康战略融资,融资额5500万人民币,投资方为赛富投资基金、海厚泰资本等
证券之星 · 05-31
【投融资动态】安徽泰恩康战略融资,融资额5500万人民币,投资方为赛富投资基金、海厚泰资本等
泰恩康上涨5.14%,报29.26元/股
金融界 · 05-30
泰恩康上涨5.14%,报29.26元/股
泰恩康新提交“里柔”商标注册申请
证券之星 · 05-24
泰恩康新提交“里柔”商标注册申请
每周股票复盘:泰恩康(301263)2024年度权益分派实施,每10股派2元
证券之星 · 05-23
每周股票复盘:泰恩康(301263)2024年度权益分派实施,每10股派2元
泰恩康:截止2025年5月20日,公司股东总户数为10,084户
证券之星 · 05-22
泰恩康:截止2025年5月20日,公司股东总户数为10,084户
【泰恩康:控股股东郑汉杰解除750万股质押股份】泰恩康公告,公司控股股东、实际控制人郑汉杰先生于2025年5月15日解除750万股质押股份,占其所持股份比例8.49%,占公司总股本比例1.76%。本次解除质押的质权人为中原信托有限公司。截至公告披露日,郑汉杰先生累计被质押股份数量为3500万股,占其所持股份比例39.60%,占公司总股本比例8.23%。
金融界 · 05-16
【泰恩康:控股股东郑汉杰解除750万股质押股份】泰恩康公告,公司控股股东、实际控制人郑汉杰先生于2025年5月15日解除750万股质押股份,占其所持股份比例8.49%,占公司总股本比例1.76%。本次解除质押的质权人为中原信托有限公司。截至公告披露日,郑汉杰先生累计被质押股份数量为3500万股,占其所持股份比例39.60%,占公司总股本比例8.23%。
泰恩康(301263)5月9日股东户数1.09万户,较上期增加12.03%
证券之星 · 05-13
泰恩康(301263)5月9日股东户数1.09万户,较上期增加12.03%
加载更多
公司概况
公司名称:
广东泰恩康医药股份有限公司
所属行业:
批发业
上市日期:
2022-03-29
主营业务:
广东泰恩康医药股份有限公司的主营业务是代理运营及研发、生产、销售医药产品、医疗器械、卫生材料并提供医药技术服务与技术转让等。公司的主要产品是盐酸达泊西汀片、他达拉非片、枸橼酸西地那非口崩片、和胃整肠丸、沃丽汀、风油精、六味地黄丸、藿香正气丸、奥硝唑注射液。
发行价格:
19.93
{"stockData":{"symbol":"301263","market":"SZ","secType":"STK","nameCN":"泰恩康","latestPrice":41.4,"timestamp":1752562995000,"preClose":40.7,"halted":0,"volume":10936603,"delay":0,"changeRate":0.0172,"floatShares":304000000,"shares":425000000,"eps":0.2217,"marketStatus":"已收盘","change":0.7,"latestTime":"07-15 15:00:00","open":40.3,"high":41.4,"low":39.29,"amount":441000000,"amplitude":0.0518,"askPrice":41.4,"askSize":0,"bidPrice":41.38,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.2217,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752629400000},"marketStatusCode":5,"adr":0,"adjPreClose":40.7,"symbolType":"stock","openAndCloseTimeList":[[1752543000000,1752550200000],[1752555600000,1752562800000]],"highLimit":44.77,"lowLimit":36.63,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":425497500,"isCdr":false,"pbRate":9.63,"roa":"--","peRate":186.738836,"roe":"1.77%","epsLYR":0.26,"committee":-0.273885,"marketValue":17616000000,"turnoverRate":0.036,"status":0,"floatMarketCap":12568000000},"requestUrl":"/m/hq/s/301263","defaultTab":"news","newsList":[{"id":"2551418239","title":"医药生物:创新药及CXO继续爆发 关注玫瑰痤疮新药(泰恩康/科笛)","url":"https://stock-news.laohu8.com/highlight/detail?id=2551418239","media":"华福证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551418239?lang=zh_cn&edition=full","pubTime":"2025-07-13 00:00","pubTimestamp":1752336000,"startTime":"0","endTime":"0","summary":"玫瑰痤疮百亿级潜在蓝海,关注泰恩康:中国玫瑰痤疮患者或达5000 万人,女性为主,自带医美属性。当前玫瑰痤疮治疗手段有限,获批药物如甲硝唑凝胶、过氧化苯甲酰、米诺环素等多为老药新用,普遍存在皮肤干燥、红斑、烧灼感等副作用,亟待有安全性及有效性均好的药物上市。经过我们测算,中国玫瑰痤疮创新药潜在市场空间或超百亿元。本周建议关注组合:信达生物、康方生物、中国生物制药、云顶新耀、海正药业、泰恩康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713185619a6a6a7c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713185619a6a6a7c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["301263","163118","BK0028","600267","000808.SH","BK0250","09926","BK0239","BK0188","159992","01177","01801","BK0060"],"gpt_icon":0},{"id":"2549833546","title":"泰恩康最新公告:全资子公司收到药品注册受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2549833546","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549833546?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:31","pubTimestamp":1751970666,"startTime":"0","endTime":"0","summary":"泰恩康(301263.SZ)公告称,公司全资子公司华铂凯盛近日收到国家药监局签发的盐酸毛果芸香碱滴眼液境内生产药品注册上市许可申请《受理通知书》。该药品为化学药品3类,规格为1.25%(2.5ml:31.25mg),申请人为华铂凯盛。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800032187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2549567184","title":"泰恩康上涨5.2%,报40.7元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549567184","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549567184?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:41","pubTimestamp":1751938873,"startTime":"0","endTime":"0","summary":"7月8日,泰恩康盘中上涨5.2%,截至09:41,报40.7元/股,成交1.52亿元,换手率1.26%,总市值173.18亿元。截至5月30日,泰恩康股东户数9998,人均流通股3.04万股。2025年1月-3月,泰恩康实现营业收入1.85亿元,同比减少2.35%;归属净利润3154.6万元,同比减少30.62%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/08094151545120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2547065043","title":"泰恩康:布局老年慢性病领域药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2547065043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547065043?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:39","pubTimestamp":1751272761,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康06月30日在投资者关系平台上答复投资者关心的问题。泰恩康回复:您好,公司在老年慢性病领域还布局了治疗前列腺增生的非那雄胺他达拉非胶囊、治疗帕金森病的盐酸普拉克索缓释片、治疗骨质疏松的阿仑膦酸钠片等,具体请查阅公司披露的《2024年年度报告》中的第三节“管理层讨论与分析”章节中的“研发投入”相关具体内容,感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000021437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2545940438","title":"泰恩康:CKBA软膏白癜风适应症II期临床试验预计7月底公布结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2545940438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545940438?lang=zh_cn&edition=full","pubTime":"2025-06-24 16:51","pubTimestamp":1750755079,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康(301263)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问:请问下CKBA白癜风2期临床结果大概具体什么时间出?能否早日与投资者分享?CKBA还会往那些方面拓展?NKBA目前有哪些进展?谢谢泰恩康回复:您好,CKBA软膏白癜风适应症II期临床试验在今年4月底已完成全部受试者的用药,预计将于今年7月底公布II期临床试验结果。后续在CKBA的靶点作用机制有效性得到进一步验证后,公司将积极拓展其他适应症。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400027078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","03347","BK1583","301263","BK0250"],"gpt_icon":0},{"id":"2544125373","title":"6月20日泰恩康发布公告,股东减持569.43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544125373","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544125373?lang=zh_cn&edition=full","pubTime":"2025-06-20 18:01","pubTimestamp":1750413700,"startTime":"0","endTime":"0","summary":"证券之星消息,6月20日泰恩康发布公告《泰恩康:关于2024年员工持股计划减持完毕的公告》,其股东广东泰恩康医药股份有限公司2024年员工持股计划于2025年6月4日至2025年6月20日间合计减持569.43万股,占公司目前总股本的1.3383%,变动期间该股股价上涨7.26%,截止6月19日收盘报32.96元。股东增减持详情见下表:根据泰恩康2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000027527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2544514793","title":"泰恩康(301263.SZ):硫酸氨基葡萄糖胶囊注册上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2544514793","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544514793?lang=zh_cn&edition=full","pubTime":"2025-06-20 17:10","pubTimestamp":1750410617,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰恩康(301263.SZ)公告,公司全资子公司安徽泰恩康制药有限公司于近日收到国家药品监督管理局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可申请《受理通知书》,国家药监局对上述药品的药品注册上市许可申请进行了审查,决定予以受理。硫酸氨基葡萄糖胶囊适用于原发性及继发性骨关节炎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2544464731","title":"中证全指食品与主要用品零售指数报9325.86点,前十大权重包含泰恩康等","url":"https://stock-news.laohu8.com/highlight/detail?id=2544464731","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544464731?lang=zh_cn&edition=full","pubTime":"2025-06-20 16:09","pubTimestamp":1750406987,"startTime":"0","endTime":"0","summary":"金融界6月20日消息,上证指数低开震荡,中证全指食品与主要用品零售指数 报9325.86点。数据统计显示,中证全指食品与主要用品零售指数近一个月下跌4.81%,近三个月下跌7.64%,年至今下跌8.34%。从中证全指食品与主要用品零售指数持仓样本的行业来看,医药商业占比44.01%、超市与便利店占比21.38%、专营零售占比20.24%、百货商店占比14.38%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/20160951198154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301263","BK0250","000985.SH"],"gpt_icon":0},{"id":"2544892453","title":"泰恩康:公司“发教授”米诺地尔搽剂本月正式上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2544892453","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544892453?lang=zh_cn&edition=full","pubTime":"2025-06-18 16:54","pubTimestamp":1750236859,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康(301263)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问贵公司治疗脱发的米诺地尔搽剂有没有产生经济效益?有没有开始批量生产上市?给营业带来什么样的影响?泰恩康回复:投资者您好,公司“发教授”米诺地尔搽剂本月正式上市销售,感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800025445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2542062353","title":"泰恩康:截止2025年6月10日,公司股东总户数为16,342户","url":"https://stock-news.laohu8.com/highlight/detail?id=2542062353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542062353?lang=zh_cn&edition=full","pubTime":"2025-06-11 16:42","pubTimestamp":1749631367,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康(301263)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截至2025年6月10日股东户数多少?谢谢!泰恩康回复:尊敬的投资者您好,截止2025年6月10日,公司股东总户数为16,342户,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100024955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2542987584","title":"医药商业板块异动拉升,泰恩康领涨12.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542987584","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542987584?lang=zh_cn&edition=full","pubTime":"2025-06-09 10:08","pubTimestamp":1749434885,"startTime":"0","endTime":"0","summary":"6月9日,医药商业板块盘中上涨1.48%,泰恩康领涨12.67%,一心堂涨超3%,老百姓、塞力医疗、百洋医药涨超2%。板块实时资金流向显示,今日超大单净流出8808.87万元,今日小单净流入4711.56万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/09100850940146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK0250","159938","BK1515","BK1161","301263","09939"],"gpt_icon":0},{"id":"2541895305","title":"每周股票复盘:泰恩康(301263)股东户数减少86户,户均持股增至4.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2541895305","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541895305?lang=zh_cn&edition=full","pubTime":"2025-06-07 05:04","pubTimestamp":1749243858,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘,泰恩康报收于31.02元,较上周的28.85元上涨7.52%。本周,泰恩康6月4日盘中最高价报31.98元,股价触及近一年最高点。泰恩康当前最新总市值131.99亿元,在化学制药板块市值排名36/150,在两市A股市值排名1197/5148。本周关注点股本股东变化:截至2025年5月30日公司股东户数为9998.0户,较5月20日减少86.0户股本股东变化近日泰恩康披露,截至2025年5月30日公司股东户数为9998.0户,较5月20日减少86.0户,减幅为0.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700007351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2540620080","title":"泰恩康:截止2025年5月30日,公司股东总户数为9,998户","url":"https://stock-news.laohu8.com/highlight/detail?id=2540620080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540620080?lang=zh_cn&edition=full","pubTime":"2025-06-04 11:35","pubTimestamp":1749008124,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康(301263)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,截止到5月30日,公司的股东人数是多少泰恩康回复:尊敬的投资者您好,截止2025年5月30日,公司股东总户数为9,998户,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400012984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2539899786","title":"【投融资动态】安徽泰恩康战略融资,融资额5500万人民币,投资方为赛富投资基金、海厚泰资本等","url":"https://stock-news.laohu8.com/highlight/detail?id=2539899786","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539899786?lang=zh_cn&edition=full","pubTime":"2025-05-31 19:19","pubTimestamp":1748690363,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于5月29日公布的信息整理,安徽泰恩康生物工程有限公司战略融资,融资额5500万人民币,参与投资的机构包括赛富投资基金,海厚泰资本。安徽泰恩康生物工程有限公司是一家药品生产商,公司主要经营许可项目:药品生产;药品进出口。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100011111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["MUCmain","301263","BK0250","CNHmain","CYB","UCmain","MCNHmain"],"gpt_icon":0},{"id":"2539131762","title":"泰恩康上涨5.14%,报29.26元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2539131762","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539131762?lang=zh_cn&edition=full","pubTime":"2025-05-30 09:55","pubTimestamp":1748570153,"startTime":"0","endTime":"0","summary":"5月30日,泰恩康盘中上涨5.14%,截至09:55,报29.26元/股,成交1.6亿元,换手率1.84%,总市值124.5亿元。截至4月18日,泰恩康股东户数9700,人均流通股3.13万股。2025年1月-3月,泰恩康实现营业收入1.85亿元,同比减少2.35%;归属净利润3154.6万元,同比减少30.62%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/30095550758641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2538197609","title":"泰恩康新提交“里柔”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2538197609","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538197609?lang=zh_cn&edition=full","pubTime":"2025-05-25 05:06","pubTimestamp":1748120790,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日广东泰恩康医药股份有限公司新提交“里柔”商标注册申请。商标申请详情如下:今年以来广东泰恩康医药股份有限公司新申请注册商标3件,截止目前公司共持有注册商标529件,另有93件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052500000231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2537150018","title":"每周股票复盘:泰恩康(301263)2024年度权益分派实施,每10股派2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537150018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537150018?lang=zh_cn&edition=full","pubTime":"2025-05-24 06:38","pubTimestamp":1748039897,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,泰恩康报收于26.64元,较上周的23.3元上涨14.33%。公司2024年度权益分派方案已获2025年5月16日召开的2024年年度股东大会审议通过。本次权益分派股权登记日为2025年5月26日,除权除息日为2025年5月27日。广东泰恩康医药股份有限公司董事会2025年5月20日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400009583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2537199062","title":"泰恩康:截止2025年5月20日,公司股东总户数为10,084户","url":"https://stock-news.laohu8.com/highlight/detail?id=2537199062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537199062?lang=zh_cn&edition=full","pubTime":"2025-05-22 16:18","pubTimestamp":1747901886,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康(301263)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问截止到5月20日,公司股东人数是多少泰恩康回复:尊敬的投资者您好,截止2025年5月20日,公司股东总户数为10,084户,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200023596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0},{"id":"2535978893","title":"【泰恩康:控股股东郑汉杰解除750万股质押股份】泰恩康公告,公司控股股东、实际控制人郑汉杰先生于2025年5月15日解除750万股质押股份,占其所持股份比例8.49%,占公司总股本比例1.76%。本次解除质押的质权人为中原信托有限公司。截至公告披露日,郑汉杰先生累计被质押股份数量为3500万股,占其所持股份比例39.60%,占公司总股本比例8.23%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535978893","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535978893?lang=zh_cn&edition=full","pubTime":"2025-05-16 20:41","pubTimestamp":1747399315,"startTime":"0","endTime":"0","summary":"泰恩康公告,公司控股股东、实际控制人郑汉杰先生于2025年5月15日解除750万股质押股份,占其所持股份比例8.49%,占公司总股本比例1.76%。本次解除质押的质权人为中原信托有限公司。截至公告披露日,郑汉杰先生累计被质押股份数量为3500万股,占其所持股份比例39.60%,占公司总股本比例8.23%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16204150462643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301263","BK0250"],"gpt_icon":0},{"id":"2535571249","title":"泰恩康(301263)5月9日股东户数1.09万户,较上期增加12.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535571249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535571249?lang=zh_cn&edition=full","pubTime":"2025-05-13 17:18","pubTimestamp":1747127939,"startTime":"0","endTime":"0","summary":"证券之星消息,近日泰恩康披露,截至2025年5月9日公司股东户数为1.09万户,较4月18日增加1167.0户,增幅为12.03%。在化学制药行业个股中,泰恩康股东户数低于行业平均水平,截至5月9日,化学制药行业平均股东户数为3.21万户。从股价来看,2025年4月18日至2025年5月9日,泰恩康区间涨幅为14.81%,在此期间股东户数增加1167.0户,增幅为12.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300026946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752614447200,"stockEarnings":[{"period":"1week","weight":0.0455},{"period":"1month","weight":0.0938},{"period":"3month","weight":1.1154},{"period":"6month","weight":1.6723},{"period":"1year","weight":2.3971},{"period":"ytd","weight":1.7828}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.0379},{"period":"3month","weight":0.0699},{"period":"6month","weight":0.0831},{"period":"1year","weight":0.1785},{"period":"ytd","weight":0.0457}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东泰恩康医药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"16342人(较上一季度增加63.45%)","perCapita":"18577股","listingDate":"2022-03-29","address":"广东省汕头市龙湖区泰山北路万吉南二街8号A幢","registeredCapital":"42549万元","survey":" 广东泰恩康医药股份有限公司的主营业务是代理运营及研发、生产、销售医药产品、医疗器械、卫生材料并提供医药技术服务与技术转让等。公司的主要产品是盐酸达泊西汀片、他达拉非片、枸橼酸西地那非口崩片、和胃整肠丸、沃丽汀、风油精、六味地黄丸、藿香正气丸、奥硝唑注射液。","listedPrice":19.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰恩康(301263)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰恩康,301263,泰恩康股票,泰恩康股票老虎,泰恩康股票老虎国际,泰恩康行情,泰恩康股票行情,泰恩康股价,泰恩康股市,泰恩康股票价格,泰恩康股票交易,泰恩康股票购买,泰恩康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰恩康(301263)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}